Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDKrystal Biotech, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | $1.29 | $1.57 | $1.43 |
| Q2 2025 | 4 | $0.92 | $1.74 | $1.18 |
| Q3 2025 | 3 | $1.03 | $1.17 | $1.09 |
| Q4 2025 | 3 | $1.30 | $1.78 | $1.50 |
| Q1 2026 | 2 | $1.38 | $1.67 | $1.52 |
| Q2 2026 | 1 | $1.76 | $2.13 | $1.94 |
| Q3 2026 | 1 | $1.94 | $2.35 | $2.14 |
| Q4 2026 | 1 | $2.21 | $2.67 | $2.43 |
| Q1 2027 | 1 | $2.59 | $3.14 | $2.86 |
| Q2 2027 | 1 | $3.16 | $3.83 | $3.49 |
| Q3 2027 | 1 | $3.67 | $4.44 | $4.04 |
| Q4 2027 | 1 | $4.32 | $5.23 | $4.76 |
Krystal Biotech, Inc. Earnings Date And Information
Krystal Biotech, Inc. last posted its earnings results on Monday, November 3rd, 2025. The company reported $2.66 earnings per share for the quarter, topping analysts' consensus estimates of $1.12 by $1.54. The company had revenue of 97.80 M for the quarter and had revenue of 290.52 M for the year. Krystal Biotech, Inc. has generated $3 earnings per share over the last year ($3 diluted earnings per share) and currently has a price-to-earnings ratio of 32.31. Krystal Biotech, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 18th, 2026 based on prior year's report dates.
Krystal Biotech, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/03/2025 | Q3 2025 | $1.12 | $2.74 | 1.62 | $93.19 M | $97.80 M |
| 08/04/2025 | Q2 2025 | $1.08 | $1.33 | 0.25 | $91.97 M | $96.04 M |
| 05/06/2025 | Q1 2025 | $1.38 | $1.24 | -0.14 | N/A | $88.18 M |
| 02/19/2025 | Q4 2024 | $1.29 | $1.58 | 0.29 | N/A | $91.14 M |
| 11/04/2024 | Q3 2024 | $0.90 | $0.95 | 0.05 | $82.94 M | $83.84 M |
| 08/05/2024 | Q2 2024 | $0.50 | $0.54 | 0.04 | $65.27 M | $70.28 M |
| 05/06/2024 | Q1 2024 | $0.15 | $0.03 | -0.12 | N/A | $45.25 M |
| 02/26/2024 | Q4 2023 | -$0.38 | $0.31 | 0.69 | N/A | $42.14 M |
| 11/06/2023 | Q3 2023 | -$1.10 | $2.88 | 3.98 | $6.29 M | $8.56 M |
| 08/07/2023 | Q2 2023 | -$0.42 | -$1.25 | -0.83 | N/A | $0 |
| 05/08/2023 | Q1 2023 | -$1.41 | -$1.76 | -0.35 | N/A | $0 |
| 02/27/2023 | Q4 2022 | -$1.39 | -$1.25 | 0.14 | N/A | $0 |
| 11/07/2022 | Q3 2022 | -$1.23 | -$1.17 | 0.06 | N/A | $0 |
| 08/08/2022 | Q2 2022 | -$1.08 | -$1.10 | -0.02 | N/A | $0 |
| 05/09/2022 | Q1 2022 | -$0.96 | -$1.99 | -1.03 | N/A | $0 |
| 02/28/2022 | Q4 2021 | -$0.76 | -$0.98 | -0.22 | N/A | $0 |
| 11/08/2021 | Q3 2021 | -$0.75 | -$0.70 | 0.05 | N/A | $0 |
| 08/09/2021 | Q2 2021 | -$0.74 | -$0.74 | 0 | N/A | $0 |
| 05/10/2021 | Q1 2021 | -$0.55 | -$0.74 | -0.19 | N/A | $0 |
| 03/01/2021 | Q4 2020 | -$0.55 | -$0.52 | 0.03 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Krystal Biotech, Inc. Earnings: FAQ's
Krystal Biotech, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 18th, 2026 based offlast year's report dates.
In the previous quarter, Krystal Biotech, Inc. (:KRYS) reported $2.66 earnings per share (EPS) to beat the analysts' consensus estimate of $1.12 by $1.54.
The conference call for Krystal Biotech, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Krystal Biotech, Inc.'s latest earnings report can be read online.
Krystal Biotech, Inc. (:KRYS) has a recorded annual revenue of $290.52 M.
Krystal Biotech, Inc. (:KRYS) has a recorded net income of $89.16 M.Krystal Biotech, Inc. has generated $3.12 earnings per share over the last four quarters.
Krystal Biotech, Inc. (:KRYS) has a price-to-earnings ratio of 32.31 and price/earnings-to-growth ratio is 0.92.